[go: up one dir, main page]

GB201304811D0 - Novel treatment for hypertension - Google Patents

Novel treatment for hypertension

Info

Publication number
GB201304811D0
GB201304811D0 GBGB1304811.1A GB201304811A GB201304811D0 GB 201304811 D0 GB201304811 D0 GB 201304811D0 GB 201304811 A GB201304811 A GB 201304811A GB 201304811 D0 GB201304811 D0 GB 201304811D0
Authority
GB
United Kingdom
Prior art keywords
hypertension
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1304811.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Cambridge Ltd
Original Assignee
Proximagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proximagen Ltd filed Critical Proximagen Ltd
Priority to GBGB1304811.1A priority Critical patent/GB201304811D0/en
Publication of GB201304811D0 publication Critical patent/GB201304811D0/en
Priority to PCT/GB2014/050811 priority patent/WO2014140631A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1304811.1A 2013-03-15 2013-03-15 Novel treatment for hypertension Ceased GB201304811D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1304811.1A GB201304811D0 (en) 2013-03-15 2013-03-15 Novel treatment for hypertension
PCT/GB2014/050811 WO2014140631A1 (en) 2013-03-15 2014-03-14 Prx933 (prx-00933), a 5ht2c agonist, for use in the treatment of hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1304811.1A GB201304811D0 (en) 2013-03-15 2013-03-15 Novel treatment for hypertension

Publications (1)

Publication Number Publication Date
GB201304811D0 true GB201304811D0 (en) 2013-05-01

Family

ID=48226505

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1304811.1A Ceased GB201304811D0 (en) 2013-03-15 2013-03-15 Novel treatment for hypertension

Country Status (2)

Country Link
GB (1) GB201304811D0 (en)
WO (1) WO2014140631A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057161A2 (en) * 2001-12-28 2003-07-17 Bayer Pharmaceuticals Corporation BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF
ES2307102T3 (en) * 2002-06-19 2008-11-16 Biovitrum Ab (Publ) PIPERAZINILPIRAZINAS AS MODULATORS OF THE SEROTONINE 5-HT2C RECEPTOR.

Also Published As

Publication number Publication date
WO2014140631A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
GB201413149D0 (en) No details
GB201420450D0 (en) Early entry
GB201411935D0 (en) Early entry
GB201319060D0 (en) Early entry
PL3021838T3 (en) Treatment for obesity
GB201416216D0 (en) Early entry
GB201507990D0 (en) Early entry
ZA201506156B (en) Novel inhibitors
GB201518344D0 (en) No details present
GB201410903D0 (en) No details
GB201418212D0 (en) No details
GB201413160D0 (en) Early entry
HUE039509T2 (en) Camshaft
GB201416327D0 (en) No details
GB201408089D0 (en) No details
GB201304872D0 (en) Treatment
GB201418129D0 (en) No details
GB201415020D0 (en) Early entry
GB201310163D0 (en) Early entry
GB201407200D0 (en) No details
GB201417843D0 (en) No details
HUE036130T2 (en) Adjustable camshaft
HUE036093T2 (en) Adjustable camshaft
GB201307310D0 (en) Treatment
GB201321961D0 (en) Early Entry

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)